Interval between Moderna COVID vaccine 2nd shot, booster still 6 months: USFDA Medical Dialogues Bureau4 Jan 2022 9:30 AM ISTWashington: The interval between receiving a second dose of Moderna's COVID-19 vaccine and a booster dose remains unchanged at six months, U.S. Food...
Fourth COVID vaccine shot for people over 60 approved in Israel Medical Dialogues Bureau4 Jan 2022 9:00 AM ISTIsrael approved the fourth vaccine shot for immune compromised people and the elderly living in care homes, becoming one of the first countries to...
Belgium to buy courses of Pfizer, Merck COVID pills Ruchika Sharma3 Jan 2022 9:00 AM ISTBrussels: Belgium has agreed to buy 10,000 courses each of the COVID-19 antiviral oral treatments developed by Pfizer and Merck & CO, a...
Pfizer-BioNTech COVID vaccine causes mostly mild side effects in children aged 5 to 11 years, says USCDC Ruchika Sharma2 Jan 2022 10:00 AM ISTNew Delhi: Pfizer Inc and BioNTech SE's COVID-19 vaccine caused mostly mild side effects in children aged 5 to 11 years, according to data...
Pfizer COVID drug Paxlovid gets approval in Britain Ruchika Sharma2 Jan 2022 9:30 AM ISTPaxlovid is made of two active substances which come as two separate pills taken twice a day together for five days.
COVID 19 drug Paxlovid Dr. Nandita Mohan1 Jan 2022 4:38 PM ISTAs the number of Omicron cases continues to increase in India and worldwide, recently approved antiviral pills could be a game-changer for the most ...
First: Beximco Pharma launches generic version of Pfizer Paxlovid for COVID treatment Ruchika Sharma31 Dec 2021 3:26 PM ISTThe company will market the product under the brand name Bexovid.
CoronaVac third dose ineffective against Omicron, says study contrary to Sinovac claim Dr Pooja27 Dec 2021 2:51 PM ISTHong Kong: China's Sinovac Covid-19 vaccine (CoronaVac) doesn't provide sufficient antibodies to fend off Omicron, a study by two Hong Kong...
Pfizer COVID pill approved in South Korea for emergency use Ruchika Sharma27 Dec 2021 12:30 PM ISTSeoul: South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID-19 as the first of its kind to be introduced in South...
Molnupiravir bags USFDA nod Dr. Nandita Mohan24 Dec 2021 6:30 PM ISTMerck and Ridgeback Biotherapeutics have announced that the U.S. Food and Drug Administration (USFDA) has granted Emergency Use Authorization (EUA)...
Tofacitinib approved by FDA for Active Ankylosing Spondylitis Dr. Nandita Mohan24 Dec 2021 3:29 PM ISTThe U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for XELJANZ / XELJANZ XR (tofacitinib) for the...
Medical Bulletin 23/December/2021 Dr. Nandita Mohan23 Dec 2021 5:30 PM ISTHere are Top Medical stories of the dayFaster transmission of the Omicron virus and why third dose might be needed A team of researchers from Hong...
